-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Lantern Pharma Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q2 2024.
- Lantern Pharma Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$5.41M, a 4.2% decline year-over-year.
- Lantern Pharma Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$19.5M, a 26.5% decline year-over-year.
- Lantern Pharma Inc. annual Operating Income (Loss) for 2023 was -$17.9M, a 23.9% decline from 2022.
- Lantern Pharma Inc. annual Operating Income (Loss) for 2022 was -$14.4M, a 14.6% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)